These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25139150)

  • 1. Comparative evaluation of efficacy of use of naftopidil and/or celecoxib for medical treatment of distal ureteral stones.
    Lv JL; Tang QL
    Urolithiasis; 2014 Dec; 42(6):541-7. PubMed ID: 25139150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones.
    Zhou SG; Lu JL; Hui JH
    World J Urol; 2011 Dec; 29(6):767-71. PubMed ID: 21845472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: a prospective randomized study.
    Lu JL; Tang QL; De Liu F; Hui JH
    Urol Res; 2012 Dec; 40(6):757-62. PubMed ID: 22926289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Naftopidil in the Medical Expulsion Therapy for Distal Ureteral Stone: A Systematic Review and Meta-Analysis.
    Li J; Tang Z; Gao L; Li J; Qin F; Yuan J
    J Endourol; 2017 May; 31(5):427-437. PubMed ID: 28306333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones.
    Sun X; He L; Ge W; Lv J
    J Urol; 2009 Apr; 181(4):1716-20. PubMed ID: 19233432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naftopidil versus flopropione as medical expulsive therapy for distal ureteral stones: results of a randomized, multicenter, double-blind, controlled trial.
    Kohjimoto Y; Hagino K; Ogawa T; Inagaki T; Kitamura S; Nishihata M; Iba A; Matsumura N; Hara I
    World J Urol; 2015 Dec; 33(12):2125-9. PubMed ID: 25869815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients.
    Tsuzaka Y; Matsushima H; Kaneko T; Yamaguchi T; Homma Y
    Int J Urol; 2011 Nov; 18(11):792-5. PubMed ID: 21917021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitation of expulsion of ureteral stones by addition of α1-blockers to conservative therapy.
    Ohgaki K; Horiuchi K; Hikima N; Kondo Y
    Scand J Urol Nephrol; 2010 Dec; 44(6):420-4. PubMed ID: 20604720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamsulosin and tolterodine in the medical expulsive therapy for intramural ureteral stones with vesical irritability: a prospective randomized study.
    Lv JL; Tang Ql
    Urolithiasis; 2013 Oct; 41(5):417-21. PubMed ID: 23963102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Naftopidil as a Medical Expulsive Therapy in Japanese Men With Ureteral Stones: A Prospective Randomized Controlled Study.
    Ohgaki K
    J Clin Med Res; 2019 Jul; 11(7):495-500. PubMed ID: 31236168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients.
    Al-Ansari A; Al-Naimi A; Alobaidy A; Assadiq K; Azmi MD; Shokeir AA
    Urology; 2010 Jan; 75(1):4-7. PubMed ID: 20109697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficiency of tamsulosin and Rowatinex in patients with distal ureteral stones: a prospective, randomized, controlled study.
    Aldemir M; Uçgül YE; Kayıgil O
    Int Urol Nephrol; 2011 Mar; 43(1):79-83. PubMed ID: 20535638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ureteral lithiasis with tamsulosin: literature review and meta-analysis.
    Arrabal-Martin M; Valle-Diaz de la Guardia F; Arrabal-Polo MA; Palao-Yago F; Mijan-Ortiz JL; Zuluaga-Gomez A
    Urol Int; 2010; 84(3):254-9. PubMed ID: 20389151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive medical therapy with an alpha-1A-specific blocker after shock wave lithotripsy of lower ureteral stones.
    Wang CJ; Huang SW; Chang CH
    Urol Int; 2009; 82(2):166-9. PubMed ID: 19322003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does tamsulosin change the management of proximally located ureteral stones?
    Yencilek F; Erturhan S; Canguven O; Koyuncu H; Erol B; Sarica K
    Urol Res; 2010 Jun; 38(3):195-9. PubMed ID: 20182703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of etoricoxib and celecoxib for pain prevention after periodontal surgery: a double-masked, parallel-group, placebo-controlled, randomized clinical trial.
    Steffens JP; Santos FA; Pilatti GL
    J Periodontol; 2011 Sep; 82(9):1238-44. PubMed ID: 21235334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi.
    Dellabella M; Milanese G; Muzzonigro G
    J Urol; 2005 Jul; 174(1):167-72. PubMed ID: 15947613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial to compare the safety and efficacy of naftopidil and tamsulosin as medical expulsive therapy in combination with prednisolone for distal ureteral stones.
    Kumar S; Kurdia KC; Ganesamoni R; Singh SK; Nanjappa B
    Korean J Urol; 2013 May; 54(5):311-5. PubMed ID: 23700496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial.
    Song YW; Lee EY; Koh EM; Cha HS; Yoo B; Lee CK; Baek HJ; Kim HA; Suh Y; Kang SW; Lee YJ; Jung HG
    Clin Ther; 2007 May; 29(5):862-873. PubMed ID: 17697905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.